drugset / Trial / NCT02652156
TAP Block for Postoperative Pain Control
RandomizedParallel-groupOpen-labelTreatment
Summary
This clinical trial will examine differences in the effectiveness between three (3) commonly used methods and/or medications used to perform a transversus abdominis plane (TAP) block for post-operative pain control. The transversus abdominis muscle is either side between the lowest rib and the hip bone. Group A subjects will undergo post-operative pain relief treatment with a single injection of Bupivacaine injected into the TAP. Group B subjects will undergo post-operative pain relief treatment with a single injection of Exparel®, a liposomal form of bupivacaine into the TAP. Group C subjects will be treated with a continuous infusion of the local anesthetic ropivacaine with the ON-Q® pump. There will be no placebo group in this study.
Timeline
- Start
- 2015-11-01
- Primary completion
- 2016-04-16
- Completion
- 2016-04-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 25 ml | Other |
| Comparator | Bupivacaine | Other / unclassified | 30 ml | Other |
| Comparator | Bupivacaine | Other / unclassified | 133 mg | Other |
| Comparator | Ropivacaine | Other / unclassified | 7 ml | — |